{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:45:31Z","timestamp":1782780331002,"version":"3.54.5"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"vor","delay-in-days":62,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-45236-3","type":"journal-article","created":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T10:57:13Z","timestamp":1777460233000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Modified Glasgow Prognostic Score as a dual biomarker for disease activity and malnutrition in inflammatory bowel disease"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-7176-5452","authenticated-orcid":false,"given":"Aysen Aytin","family":"Karzan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5903-6559","authenticated-orcid":false,"given":"\u00c7a\u011fda\u015f","family":"Erdo\u011fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8734-2518","authenticated-orcid":false,"given":"Hale","family":"Akp\u0131nar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,29]]},"reference":[{"issue":"10114","key":"45236_CR1","doi-asserted-by":"publisher","first-page":"2769","DOI":"10.1016\/S0140-6736(17)32448-0","volume":"390","author":"SC Ng","year":"2018","unstructured":"Ng, S. C. et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet 390 (10114), 2769\u20132778 (2018).","journal-title":"Lancet"},{"issue":"1","key":"45236_CR2","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S2468-1253(19)30333-4","volume":"5","author":"GBD 2017 Inflammatory Bowel Disease Collaborators","year":"2020","unstructured":"GBD 2017 Inflammatory Bowel Disease Collaborators. The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol. Hepatol. 5 (1), 17\u201330 (2020).","journal-title":"Lancet Gastroenterol. Hepatol."},{"issue":"1","key":"45236_CR3","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.mayocp.2018.09.013","volume":"94","author":"G P Ramos","year":"2019","unstructured":"P Ramos, G. & A Papadakis, K. Mechanisms of disease: inflammatory bowel diseases. Mayo Clin. Proc. 94 (1), 155\u2013165 (2019).","journal-title":"Mayo Clin. Proc."},{"issue":"27","key":"45236_CR4","doi-asserted-by":"publisher","first-page":"2652","DOI":"10.1056\/NEJMra2002697","volume":"383","author":"JT Chang","year":"2020","unstructured":"Chang, J. T. Pathophysiology of inflammatory bowel diseases. N Engl. J. Med. 383 (27), 2652\u20132664 (2020).","journal-title":"N Engl. J. Med."},{"issue":"9","key":"45236_CR5","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1038\/ajg.2015.233","volume":"110","author":"L Peyrin-Biroulet","year":"2015","unstructured":"Peyrin-Biroulet, L. et al. Selecting therapeutic targets in inflammatory bowel disease (STRIDE): determining therapeutic goals for treat-to-target. Am. J. Gastroenterol. 110 (9), 1324\u20131338 (2015).","journal-title":"Am. J. Gastroenterol."},{"issue":"6","key":"45236_CR6","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1038\/ajg.2015.120","volume":"110","author":"MH Mosli","year":"2015","unstructured":"Mosli, M. H. et al. C-reactive protein, fecal calprotectin, and stool lactoferrin for detection of endoscopic activity in symptomatic inflammatory bowel disease patients: a systematic review and meta-analysis. Am. J. Gastroenterol. 110 (6), 802\u2013819 (2015).","journal-title":"Am. J. Gastroenterol."},{"issue":"1","key":"45236_CR7","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1097\/00005176-200107000-00003","volume":"33","author":"SK Bunn","year":"2001","unstructured":"Bunn, S. K. et al. Fecal calprotectin: validation as a noninvasive measure of bowel inflammation in childhood inflammatory bowel disease. J. Pediatr. Gastroenterol. Nutr. 33 (1), 14\u201322. https:\/\/doi.org\/10.1097\/00005176-200107000-00003 (2001).","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"issue":"3","key":"45236_CR8","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1136\/gut.2005.069476","volume":"55","author":"S Vermeire","year":"2006","unstructured":"Vermeire, S., Van Assche, G. & Rutgeerts, P. Laboratory markers in IBD: useful, magic, or unnecessary toys? Gut 55 (3), 426\u2013431 (2006).","journal-title":"Gut"},{"issue":"2","key":"45236_CR9","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.clnu.2016.12.027","volume":"36","author":"A Forbes","year":"2017","unstructured":"Forbes, A. et al. ESPEN guideline: clinical nutrition in inflammatory bowel disease. Clin. Nutr. 36 (2), 321\u2013347 (2017).","journal-title":"Clin. Nutr."},{"issue":"6","key":"45236_CR10","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.clnu.2013.03.020","volume":"32","author":"S Massironi","year":"2013","unstructured":"Massironi, S. et al. Nutritional deficiencies in inflammatory bowel disease: therapeutic approaches. Clin. Nutr. 32 (6), 904\u2013910 (2013).","journal-title":"Clin. Nutr."},{"issue":"1","key":"45236_CR11","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1093\/ibd\/izy212","volume":"25","author":"E Ryan","year":"2019","unstructured":"Ryan, E. et al. Sarcopenia and inflammatory bowel disease: a systematic review. Inflamm. Bowel Dis. 25 (1), 67\u201373 (2019).","journal-title":"Inflamm. Bowel Dis."},{"issue":"28","key":"45236_CR12","doi-asserted-by":"publisher","first-page":"3823","DOI":"10.3748\/wjg.v25.i28.3823","volume":"25","author":"S Li","year":"2019","unstructured":"Li, S. et al. Systematic review of nutrition screening and assessment in inflammatory bowel disease. World J. Gastroenterol. 25 (28), 3823\u20133837 (2019).","journal-title":"World J. Gastroenterol."},{"issue":"10","key":"45236_CR13","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1002\/ibd.22906","volume":"18","author":"C Hwang","year":"2012","unstructured":"Hwang, C., Ross, V. & Mahadevan, U. Micronutrient deficiencies in inflammatory bowel disease: from A to zinc. Inflamm. Bowel Dis. 18 (10), 1961\u20131981 (2012).","journal-title":"Inflamm. Bowel Dis."},{"issue":"5","key":"45236_CR14","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.ctrv.2012.08.003","volume":"39","author":"DC McMillan","year":"2013","unstructured":"McMillan, D. C. The systemic inflammation-based Glasgow Prognostic Score: a decade of experience in patients with cancer. Cancer Treat. Rev. 39 (5), 534\u2013540 (2013).","journal-title":"Cancer Treat. Rev."},{"issue":"17","key":"45236_CR15","doi-asserted-by":"publisher","first-page":"2633","DOI":"10.1016\/j.ejca.2011.03.028","volume":"47","author":"MJ Proctor","year":"2011","unstructured":"Proctor, M. J. et al. A comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow Inflammation Outcome Study. Eur. J. Cancer. 47 (17), 2633\u20132641 (2011).","journal-title":"Eur. J. Cancer"},{"issue":"4","key":"45236_CR16","first-page":"372","volume":"50","author":"T Kubo","year":"2020","unstructured":"Kubo, T. et al. Impact of the perioperative Glasgow prognostic score for immunological and nutritional status on long-term survival after curative gastrectomy for gastric cancer. Surg. Today. 50 (4), 372\u2013379 (2020).","journal-title":"Surg. Today"},{"issue":"1","key":"45236_CR17","first-page":"1","volume":"34","author":"L Fan","year":"2022","unstructured":"Fan, L. et al. Systemic inflammation markers predict survival in patients with hepatocellular carcinoma: a meta-analysis. Eur. J. Gastroenterol. Hepatol. 34 (1), 1\u201310 (2022).","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"45236_CR18","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.critrevonc.2017.06.002","volume":"116","author":"RD Dolan","year":"2017","unstructured":"Dolan, R. D. et al. The role of the systemic inflammatory response in predicting outcomes in patients with advanced inoperable cancer: systematic review and meta-analysis. Crit. Rev. Oncol. Hematol. 116, 134\u2013146 (2017).","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"12","key":"45236_CR19","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1002\/ibd.20520","volume":"14","author":"JD Lewis","year":"2008","unstructured":"Lewis, J. D. et al. Use of the noninvasive components of the Mayo score to assess clinical response in ulcerative colitis. Inflamm. Bowel Dis. 14 (12), 1660\u20131666. https:\/\/doi.org\/10.1002\/ibd.20520 (2008).","journal-title":"Inflamm. Bowel Dis."},{"issue":"8167","key":"45236_CR20","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/s0140-6736(80)92767-1","volume":"1","author":"RF Harvey","year":"1980","unstructured":"Harvey, R. F. & Bradshaw, J. M. A simple index of Crohn\u2019s-disease activity. Lancet 1 (8167), 514. https:\/\/doi.org\/10.1016\/s0140-6736(80)92767-1 (1980).","journal-title":"Lancet"},{"issue":"7","key":"45236_CR21","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1177\/0148607115579938","volume":"40","author":"SL Lim","year":"2016","unstructured":"Lim, S. L., Lin, X. H. & Daniels, L. Seven-Point Subjective Global Assessment Is More Time Sensitive Than Conventional Subjective Global Assessment in Detecting Nutrition Changes. JPEN J. Parenter. Enter. Nutr. 40 (7), 966\u2013972. https:\/\/doi.org\/10.1177\/0148607115579938 (2016).","journal-title":"JPEN J. Parenter. Enter. Nutr."},{"key":"45236_CR22","doi-asserted-by":"publisher","DOI":"10.1002\/ncp.10613","author":"D Duerksen","year":"2020","unstructured":"Duerksen, D., Laporte, M. & Jeejeebhoy, K. Evaluation of Nutrition Status Using the Subjective Global Assessment: Malnutrition, Cachexia, and Sarcopenia. Nutr. Clin. practice: official publication Am. Soc. Parenter. Enter. Nutr. https:\/\/doi.org\/10.1002\/ncp.10613 (2020).","journal-title":"Nutr. Clin. practice: official publication Am. Soc. Parenter. Enter. Nutr."},{"issue":"5","key":"45236_CR23","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1053\/j.jrn.2017.04.006","volume":"27","author":"SS Sum","year":"2017","unstructured":"Sum, S. S. et al. Comparison of Subjective Global Assessment and Protein Energy Wasting Score to Nutrition Evaluations Conducted by Registered Dietitian Nutritionists in Identifying Protein Energy Wasting Risk in Maintenance Hemodialysis Patients. J. Ren. Nutr. 27 (5), 325\u2013332. https:\/\/doi.org\/10.1053\/j.jrn.2017.04.006 (2017).","journal-title":"J. Ren. Nutr."},{"key":"45236_CR24","doi-asserted-by":"publisher","unstructured":"\u0130rem, O., Eminsoy, G. & K\u0131z\u0131ltan Mehtap Ak\u00e7il Ok, et.al. Adaptation of the 7-Points Subjective Global Assessment (SGA-7P) into Turkish and Evaluation of SGA-3P Compliance with Pilot Study on Hemodialysis Patients. Bes Diy Derg, 47(3), 34\u201345. (2019). https:\/\/doi.org\/10.33076\/2020.BDD.1219","DOI":"10.33076\/2020.BDD.1219"},{"issue":"6","key":"45236_CR25","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1016\/j.clnu.2004.09.012","volume":"23","author":"UG Kyle","year":"2004","unstructured":"Kyle, U. G. et al. Bioelectrical impedance analysis-part II: utilization in clinical practice. Clin. Nutr. 23 (6), 1430\u20131453. https:\/\/doi.org\/10.1016\/j.clnu.2004.09.012 (2004).","journal-title":"Clin. Nutr."},{"issue":"5","key":"45236_CR26","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1002\/(sici)1097-0142(19990301)85:5<1186::aid-cncr24>3.0.co;2-n","volume":"85","author":"TR Mendoza","year":"1999","unstructured":"Mendoza, T. R. et al. The rapid assessment of fatigue severity in cancer patients: use of the Brief Fatigue Inventory. Cancer 85 (5), 1186\u20131196. https:\/\/doi.org\/10.1002\/(sici)1097-0142(19990301)85:5%3C1186::aid-cncr24%3E3.0.co;2-n (1999).","journal-title":"Cancer"},{"key":"45236_CR27","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.2147\/IJGM.S502142","volume":"18","author":"DD Wang","year":"2025","unstructured":"Wang, D. D. et al. Management of Fatigue in Inflammatory Bowel Disease: A Narrative Review. Int. J. Gen. Med. 18, 1403\u20131413. https:\/\/doi.org\/10.2147\/IJGM.S502142 (2025). Published 2025 Mar 10.","journal-title":"Int. J. Gen. Med."},{"issue":"2","key":"45236_CR28","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1136\/gutjnl-2011-300049","volume":"61","author":"L Peyrin-Biroulet","year":"2012","unstructured":"Peyrin-Biroulet, L. et al. Development of the first disability index for inflammatory bowel disease based on the international classification of functioning, disability and health. Gut 61 (2), 241\u2013247. https:\/\/doi.org\/10.1136\/gutjnl-2011-300049 (2012).","journal-title":"Gut"},{"issue":"1","key":"45236_CR29","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1111\/jgh.14496","volume":"34","author":"E Paulides","year":"2019","unstructured":"Paulides, E. et al. Validation of the inflammatory bowel disease disability index for self-report and development of an item-reduced version. J. Gastroenterol. Hepatol. 34 (1), 92\u2013102. https:\/\/doi.org\/10.1111\/jgh.14496 (2019).","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"36","key":"45236_CR30","first-page":"e39562","volume":"103","author":"M Dayangac","year":"2024","unstructured":"Dayangac, M. et al. The relationship between Glasgow Prognostic Score and hospital duration in patients with inflammatory bowel diseases. Med. (Baltim). 103 (36), e39562 (2024).","journal-title":"Med. (Baltim)."},{"issue":"11\u201312","key":"45236_CR31","first-page":"378","volume":"130","author":"S G\u0142uszek","year":"2018","unstructured":"G\u0142uszek, S. et al. The modified Glasgow prognostic score in Crohn\u2019s disease\u2014does it predict short-term outcome? Wien Klin. Wochenschr. 130 (11\u201312), 378\u2013382 (2018).","journal-title":"Wien Klin. Wochenschr"},{"issue":"1","key":"45236_CR32","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1038\/s41598-018-19208-1","volume":"8","author":"C Zhao","year":"2018","unstructured":"Zhao, C. et al. Validation and optimization of the systemic inflammation-based modified Glasgow prognostic score in predicting postoperative outcome of inflammatory bowel disease: preliminary data. Sci. Rep. 8 (1), 956 (2018).","journal-title":"Sci. Rep."},{"key":"45236_CR33","first-page":"3467419","volume":"2020","author":"A Sobolewska-Wlodarczyk","year":"2020","unstructured":"Sobolewska-Wlodarczyk, A. et al. The relationship between C-reactive protein\/albumin ratio and disease activity in patients with inflammatory bowel disease. Dis. Markers. 2020, 3467419 (2020).","journal-title":"Dis. Markers"},{"issue":"8","key":"45236_CR34","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1002\/jgh3.12948","volume":"7","author":"KH Katsanos","year":"2023","unstructured":"Katsanos, K. H. et al. Clinical utility of C-reactive protein-to-albumin ratio in the management of patients with inflammatory bowel disease. JGH Open. 7 (8), 559\u2013566 (2023).","journal-title":"JGH Open."},{"key":"45236_CR35","first-page":"628","volume":"22","author":"A Sobolewska-Wlodarczyk","year":"2016","unstructured":"Sobolewska-Wlodarczyk, A. et al. Serum albumin and C-reactive protein\/albumin ratio are useful biomarkers of Crohn\u2019s disease activity. Med. Sci. Monit. 22, 628\u2013633 (2016).","journal-title":"Med. Sci. Monit."},{"issue":"7","key":"45236_CR36","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1093\/ibd\/izad146","volume":"30","author":"D Casas-Deza","year":"2024","unstructured":"Casas-Deza, D. et al. Prevalence of disease-related malnutrition and micronutrients deficit in patients with inflammatory bowel disease: a multicentric cross-sectional study by the GSMII. Inflamm. Bowel Dis. 30 (7), 1112\u20131121 (2024).","journal-title":"Inflamm. Bowel Dis."},{"issue":"8","key":"45236_CR37","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.3390\/nu15081991","volume":"15","author":"L B\u00e4rebring","year":"2023","unstructured":"B\u00e4rebring, L. et al. Nutritional status and its detection in patients with inflammatory bowel diseases. Nutrients 15 (8), 1991 (2023).","journal-title":"Nutrients"},{"issue":"6","key":"45236_CR38","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/S2468-1253(23)00011-0","volume":"8","author":"S Massironi","year":"2023","unstructured":"Massironi, S. et al. Inflammation and malnutrition in inflammatory bowel disease. Lancet Gastroenterol. Hepatol. 8 (6), 579\u2013590 (2023).","journal-title":"Lancet Gastroenterol. Hepatol."},{"issue":"6","key":"45236_CR39","first-page":"1309","volume":"37","author":"T Cederholm","year":"2022","unstructured":"Cederholm, T. et al. Nutrition considerations in inflammatory bowel disease. Nutr. Clin. Pract. 37 (6), 1309\u20131325 (2022).","journal-title":"Nutr. Clin. Pract."},{"issue":"12","key":"45236_CR40","first-page":"3615","volume":"65","author":"D Busquets","year":"2020","unstructured":"Busquets, D. et al. Novel inflammatory-nutritional biomarkers as predictors of histological activity in Crohn\u2019s disease. Dig. Dis. Sci. 65 (12), 3615\u20133625 (2020).","journal-title":"Dig. Dis. Sci."},{"issue":"1","key":"45236_CR41","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/jgh.16747","volume":"40","author":"KC Sandberg","year":"2025","unstructured":"Sandberg, K. C. et al. Albumin and its role in inflammatory bowel disease: the old, the new, and the future. J. Gastroenterol. Hepatol. 40 (1), 19\u201328 (2025).","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"9","key":"45236_CR42","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1002\/ibd.20178","volume":"13","author":"MA Denis","year":"2007","unstructured":"Denis, M. A., Reenaers, C., Fontaine, F., Bela\u00efche, J. & Louis, E. Assessment of endoscopic activity index and biological inflammatory markers in clinically active Crohn\u2019s disease with normal C-reactive protein serum level. Inflamm. Bowel Dis. 13 (9), 1100\u20131105. https:\/\/doi.org\/10.1002\/ibd.20178 (2007).","journal-title":"Inflamm. Bowel Dis."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-45236-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-45236-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-45236-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:04:43Z","timestamp":1782777883000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-45236-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,29]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["45236"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-45236-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,29]]},"assertion":[{"value":"16 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19896"}}